Page 9 - tmp

Laparoscopic Cholecystectomy for Acute Cholecystitis
Flowchart 1: Consort flow diagram of the various stages of trial

Table 1: Clinical data and laboratory results of patients
Variables ELC group (N = 50) DLC group (N = 50) p value
Age (mean), years 41.0 ± 12.29 38.04 ± 11.38 0.195
Sex: Male 8 (16) 10 (20) 0.603
Female 42 (84) 40 (80)
2
BMI (kg/m ) 23.38 ± 2.72 22.93 ± 2.78 0.414
ASA I/II I/II —
Clinical feature
Pain duration, mean (hours) 25.0 ± 9.539 23.24 ± 7.305 0.199
Frist attack 34 (68) 36 (72) —
Previous biliary symptoms 16 (32) 18 (36) 0.673
Previous antibiotics administration 5 (10) 49 (98) <0.001
°
Temperature ( F), mean 99.8 ± 0.1 99.9 ± 0.2 0.612
Nausea/vomiting 49 (98) 49 (98) 1.00
RHC pain 50 (100) 50 (100) 1.00
Murphy’s sign 45 (90) 40 (80) 0.161
Laboratory finding
Hemoglobin gm/dL 12.886 ± 1.15 12.45 ± 1.17 0.543
3
*
White blood cells(N 10 ) 13.04 ± 2.59 12.20 ± 2.49 0.194
Serum bilirubin(mg/dL) 0.867 ± 0.22 0.740 ± 0.14 0.392
SGOT (IU/L) 46.66 ± 18.28 36.96 ± 11.41 0.090
SGPT (IU/L) 47.92 ± 19.97 38.16 ± 14.14 0.071
ALP (IU/L) 215.38 ± 90.07 179 ± 52.98 0.065
Serum amylase (IU/L) 55.16 ± 22.12 36.58 ± 8.79 0.081
Comorbidities
Diabetes mellitus 3 (6) 3 (6) 0.648
Hypertension 5 (10) 6 (12)
COPD 1 (2) 1 (2)
Hypothyroidism 1 (2) 2 (4)
RHC, right hypochondrium; Figure in parentheses denotes percentage
World Journal of Laparoscopic Surgery, Volume 14 Issue 3 (September–December 2021) 151